Showing results (771-780 of 785) with videos related to
Sort By:
Pageof 79
Bioorganic & Medicinal Chemistry|February 11, 2016
2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonistsJihyae Ann, Yooran Ki, Suyoung Yoon, et al.JCI Insight|January 27, 2026
Rare variable M. tuberculosis antigens induce predominant Th17 responses in human infectionPaul Ogongo, Liya Wassie, Anthony Tran, et al.Journal of Medicinal Chemistry|June 27, 2003
N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptorJeewoo Lee, Jiyoun Lee, Myungshim Kang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.Ebiomedicine|February 28, 2026
Infection with Mycobacterium tuberculosis depletes host fatty acids in humans and non-human primatesJeffrey M Collins, Liya Wassie, Kidist Bobosha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.Annals of Surgery|October 27, 2015
Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled TrialThomas R Ziegler, Addison K May, Gautam Hebbar, et al.Journal of Medicinal Chemistry|September 11, 2012
2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-regionMyeong Seop Kim, HyungChul Ryu, Dong Wook Kang, et al.The Journal of Infectious Diseases|May 8, 2025
A plasma metabolic signature to diagnose pulmonary tuberculosis and monitor treatment responseJeffrey M Collins, Kidist Bobosha, Naythra Narayanan, et al.Bioorganic & Medicinal Chemistry Letters|July 12, 2005
Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonistsJeewoo Lee, Sang-Uk Kang, Min-Jung Kil, et al.Pageof 79